Atria Investments Inc Has $2.14 Million Stock Holdings in HCA Healthcare, Inc. $HCA

Atria Investments Inc lowered its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 19.8% during the third quarter, HoldingsChannel.com reports. The fund owned 5,025 shares of the company’s stock after selling 1,242 shares during the period. Atria Investments Inc’s holdings in HCA Healthcare were worth $2,141,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of the stock. Cerity Partners LLC boosted its holdings in HCA Healthcare by 13.1% during the third quarter. Cerity Partners LLC now owns 43,920 shares of the company’s stock worth $18,719,000 after buying an additional 5,092 shares during the last quarter. Swiss National Bank grew its holdings in HCA Healthcare by 4.3% during the second quarter. Swiss National Bank now owns 558,900 shares of the company’s stock valued at $214,115,000 after purchasing an additional 23,100 shares during the period. Savant Capital LLC raised its holdings in HCA Healthcare by 37.7% in the third quarter. Savant Capital LLC now owns 4,548 shares of the company’s stock worth $1,938,000 after purchasing an additional 1,246 shares during the period. Sector Gamma AS increased its position in shares of HCA Healthcare by 36.0% in the 3rd quarter. Sector Gamma AS now owns 10,883 shares of the company’s stock valued at $4,638,000 after buying an additional 2,883 shares in the last quarter. Finally, National Pension Service grew its stake in HCA Healthcare by 2.9% in the third quarter. National Pension Service now owns 626,585 shares of the company’s stock valued at $267,051,000 after acquiring an additional 17,531 shares during the period. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Stock Performance

HCA opened at $534.53 on Wednesday. The business’s 50-day simple moving average is $484.82 and its 200 day simple moving average is $452.18. The firm has a market capitalization of $119.53 billion, a PE ratio of 18.83, a PEG ratio of 1.66 and a beta of 1.36. HCA Healthcare, Inc. has a 52-week low of $295.00 and a 52-week high of $552.90.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Tuesday, January 27th. The company reported $8.01 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.37 by $0.64. The company had revenue of $19.51 billion for the quarter, compared to analysts’ expectations of $19.67 billion. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The business’s revenue was up 6.7% compared to the same quarter last year. During the same quarter in the prior year, the business posted $6.22 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, research analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be issued a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend is Tuesday, March 17th. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.72. HCA Healthcare’s payout ratio is currently 10.15%.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on HCA. Robert W. Baird lifted their price objective on HCA Healthcare from $423.00 to $450.00 and gave the company a “neutral” rating in a report on Thursday, December 11th. Cantor Fitzgerald upped their price target on shares of HCA Healthcare from $525.00 to $588.00 and gave the company an “overweight” rating in a report on Wednesday, January 28th. Argus raised their price objective on shares of HCA Healthcare from $530.00 to $560.00 and gave the stock a “buy” rating in a report on Friday, February 6th. TD Cowen reissued a “buy” rating on shares of HCA Healthcare in a research note on Wednesday, January 28th. Finally, Barclays increased their price objective on HCA Healthcare from $494.00 to $551.00 and gave the stock an “overweight” rating in a report on Wednesday, January 28th. Sixteen equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $523.27.

Insider Buying and Selling

In other HCA Healthcare news, SVP Jennifer Berres sold 8,020 shares of the company’s stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $514.58, for a total value of $4,126,931.60. Following the sale, the senior vice president owned 11,993 shares in the company, valued at $6,171,357.94. This represents a 40.07% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, SVP Christopher F. Wyatt sold 4,000 shares of the firm’s stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $505.00, for a total value of $2,020,000.00. Following the sale, the senior vice president directly owned 44,379 shares of the company’s stock, valued at $22,411,395. This represents a 8.27% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 13,520 shares of company stock worth $6,894,067. Company insiders own 1.30% of the company’s stock.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.